ACM
EBS icon

Atlanta Capital Management’s Emergent Biosolutions EBS Stock Holding History

Atlanta Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-437,951
Closed -$21.9M – 173
2021
Q3 		$21.9M Sell
437,951
-16,454
-4% -$996K 0.08% 164
2021
Q2 		$28.6M Buy
454,405
+1,808
+0.4% +$116K 0.1% 155
2021
Q1 		$42.1M Buy
452,597
+5,613
+1% +$575K 0.15% 137
2020
Q4 		$40M Buy
446,984
+10,015
+2% +$919K 0.14% 136
2020
Q3 		$45.2M Sell
436,969
-223,883
-34% -$24.1M 0.19% 125
2020
Q2 		$52.3M Sell
660,852
-59,432
-8% -$4.43M 0.22% 111
2020
Q1 		$41.7M Buy
720,284
+138,804
+24% +$8M 0.22% 105
2019
Q4 		$31.4M Sell
581,480
-19,083
-3% -$1.04M 0.13% 125
2019
Q3 		$31.4M Buy
600,563
+88,306
+17% +$4.11M 0.14% 121
2019
Q2 		$24.7M Buy
512,257
+44,789
+10% +$2.15M 0.11% 131
2019
Q1 		$23.6M Buy
467,468
+204,807
+78% +$12.1M 0.11% 132
2018
Q4 		$15.6M Buy
+262,661
New +$16.9M 0.09% 143

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlanta Capital Management's EBS Position: Q4 2021 in Review

Atlanta Capital Management sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 437,951 shares — an estimated $21.9M sold.

Atlanta Capital Management first reported a position in EBS in Q4 2018 and held it in 12 quarters. The position peaked at $52.3M in Q2 2020. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Atlanta Capital Management reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Atlanta Capital Management sold 437,951 Emergent Biosolutions shares in Q4 2021, an estimated $21.9M.
  • Atlanta Capital Management first reported a position in Emergent Biosolutions in Q4 2018 and held it in 12 quarters.
  • Atlanta Capital Management's Emergent Biosolutions position peaked at $52.3M in Q2 2020.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Atlanta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.